Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fake Products Hurting China (China)

This article was originally published in PharmAsia News

Executive Summary

China will not be able to convince the international community that Chinese corporate distribution of fraudulent and toxic medicine and food has ended because it tried and executed its former drug safety agency head. Recent scandals have eroded global confidence in the "Made in China" label. China will have to take more serious widespread actions to enforce product safety laws and regain its former global reputation. Today the World Health Organization hypothesizes that 25 percent of medicine consumed in developing countries may be counterfeit. China's solution to this problem is a key part of the global fake drug puzzle. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066339

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel